Jeffrey W. Albers - Aug 16, 2022 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
Director
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Stock symbol
BPMC
Transactions as of
Aug 16, 2022
Transactions value $
-$1,199,453
Form type
4
Date filed
8/18/2022, 07:55 PM
Previous filing
Aug 10, 2022
Next filing
Aug 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $18.7K +10K +5.46% $1.87* 193K Aug 16, 2022 Direct F1
transaction BPMC Common Stock Options Exercise $150K +10K +5.17% $15.01 203K Aug 16, 2022 Direct F1
transaction BPMC Common Stock Sale -$492K -7.23K -3.56% $68.01 196K Aug 16, 2022 Direct F1, F2
transaction BPMC Common Stock Sale -$856K -12.5K -6.37% $68.62 184K Aug 16, 2022 Direct F1, F3
transaction BPMC Common Stock Sale -$20.4K -293 -0.16% $69.52 183K Aug 16, 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -10K -8.69% $0.00 105K Aug 16, 2022 Common Stock 10K $1.87 Direct F1, F5
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -10K -20% $0.00 40K Aug 16, 2022 Common Stock 10K $15.01 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effected pursuant to a trading plan adopted on January 11, 2022 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $67.31 to $68.31 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4).
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $68.32 to $69.20 per share.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $69.35 to $69.72 per share.
F5 This option was granted on July 30, 2014 and is fully vested as of the date hereof.
F6 This option was granted on February 3, 2016 and is fully vested as of the date hereof.